[Effect of combined synthetic progestins on blood coagulation properties and alpha 2-glycoprotein content].
D000293:Adolescent; D000328:Adult; D001777:Blood Coagulation / Q000187:drug effects*; D004359:Drug Therapy, Combination; D004715:Endometriosis / Q000188:drug therapy; D045166:Estradiol Congeners / Q000008:administration & dosage* / Q000494:pharmacology*; D005260:Female; D006023:Glycoproteins / Q000097:blood*; D006801:Humans; D008875:Middle Aged; D045167:Progesterone Congeners / Q000008:administration & dosage / Q000494:pharmacology*; D014592:Uterine Hemorrhage / Q000188:drug therapy; D014594:Uterine Neoplasms / Q000188:drug therapy
D045166:Estradiol Congeners; D006023:Glycoproteins; D045167:Progesterone Congeners
Vliianie kombinirovannykh sinteticheskikh progestinov na koaguliatsionnye svoĭstva krovi i soderzhanie alpha 2-glikoproteida.